Activation of the NRF2–ARE pathway is found in the MCF7 breast cancer cell line and is necessary for chemoresistance under hypoxia through the ROS–NRF2–GCLC–GSH pathway [36]. Here, NFE2L2 is linked to breast carcinoma.